D.A. Davidson & Co’s NovoCure NVCR Stock Holding History
Bought
Maintained
Sold
Other funds holding NVCR
DTC
D.A. Davidson & Co's NVCR Position: Q3 2023 in Review
D.A. Davidson & Co sold out of NovoCure (NVCR) in Q3 2023, closing a stake of 5,940 shares — an estimated $247K sold.
D.A. Davidson & Co first reported a position in NVCR in Q2 2018 and held it in 15 quarters. The position peaked at $1.12M in Q2 2021. 226 funds tracked by Wall St. Rank hold NVCR as of Q3 2023.
- D.A. Davidson & Co reported no remaining NovoCure position as of Q3 2023 after selling out during the quarter.
- D.A. Davidson & Co sold 5,940 NovoCure shares in Q3 2023, an estimated $247K.
- D.A. Davidson & Co first reported a position in NovoCure in Q2 2018 and held it in 15 quarters.
- D.A. Davidson & Co's NovoCure position peaked at $1.12M in Q2 2021.
- 226 funds tracked by Wall St. Rank held NovoCure as of Q3 2023.
Based on D.A. Davidson & Co's 13F filing for Q3 2023, filed 8 Nov 2023.